Ammunition Market (By Caliber: Small, Medium, Large, Artillery, Mortar; By Product: Rimfire, Centrefire; By End User: Civil & Commercial, Defense; By Component: Fuses & Primers, Gun Powder, Projectile, Cases, Others; By Type: Bullets, Aerial Bombs, Grenades, Mortars, Artillery Shells, Others; By Guidance: Guided, Non-guided; By Lethality: Lethal, Less-lethal) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Ammunition Market, by Caliber, 2022-2030
7.1.1. Small
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Medium
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Large
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Artillery
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Mortar
7.1.5.1. Market Revenue and Forecast (2017-2030)
8.1. Ammunition Market, by Product, 2022-2030
8.1.1. Rimfire
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Centrefire
8.1.2.1. Market Revenue and Forecast (2017-2030)
9.1. Ammunition Market, by End User, 2022-2030
9.1.1. Civil & Commercial
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Defense
9.1.2.1. Market Revenue and Forecast (2017-2030)
10.1. Ammunition Market, by Component, 2022-2030
10.1.1. Fuses & Primers
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Gun Powder
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Projectile
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Cases
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
11.1. Ammunition Market, by Type, 2022-2030
11.1.1. Bullets
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Aerial Bombs
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Grenades
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Mortars
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Artillery Shells
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017-2030)
12.1. Ammunition Market, by Guidance, 2022-2030
12.1.1. Guided
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Non-guided
12.1.2.1. Market Revenue and Forecast (2017-2030)
13.1. Ammunition Market, by Lethality, 2022-2030
13.1.1. Lethal
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Less-lethal
13.1.2.1. Market Revenue and Forecast (2017-2030)
14.1. Ammunition Market, by End-Use, 2022-2030
14.1.1. Military & Homeland Security
14.1.1.1. Market Revenue and Forecast (2017-2030)
14.1.2. Civil & Commercial
14.1.2.1. Market Revenue and Forecast (2017-2030)
14.1.3. Others
14.1.3.1. Market Revenue and Forecast (2017-2030)
15.1. North America
15.1.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.1.2. Market Revenue and Forecast, by Product (2017-2030)
15.1.3. Market Revenue and Forecast, by End User (2017-2030)
15.1.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.5. Market Revenue and Forecast, by Type (2017-2030)
15.1.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.1.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.1.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.1.9. U.S.
15.1.9.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.1.9.2. Market Revenue and Forecast, by Product (2017-2030)
15.1.9.3. Market Revenue and Forecast, by End User (2017-2030)
15.1.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.9.5. Market Revenue and Forecast, by Type (2017-2030)
15.1.9.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.1.9.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.1.9.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.1.10.2. Market Revenue and Forecast, by Product (2017-2030)
15.1.10.3. Market Revenue and Forecast, by End User (2017-2030)
15.1.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.10.5. Market Revenue and Forecast, by Type (2017-2030)
15.1.10.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.1.10.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.1.10.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.2. Europe
15.2.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.2.2. Market Revenue and Forecast, by Product (2017-2030)
15.2.3. Market Revenue and Forecast, by End User (2017-2030)
15.2.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.5. Market Revenue and Forecast, by Type (2017-2030)
15.2.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.2.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.2.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.2.9. UK
15.2.9.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
15.2.9.3. Market Revenue and Forecast, by End User (2017-2030)
15.2.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.9.5. Market Revenue and Forecast, by Type (2017-2030)
15.2.9.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.2.9.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.2.9.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.2.10. Germany
15.2.10.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.2.10.2. Market Revenue and Forecast, by Product (2017-2030)
15.2.10.3. Market Revenue and Forecast, by End User (2017-2030)
15.2.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.10.5. Market Revenue and Forecast, by Type (2017-2030)
15.2.10.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.2.10.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.2.10.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.2.11. France
15.2.11.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.2.11.2. Market Revenue and Forecast, by Product (2017-2030)
15.2.11.3. Market Revenue and Forecast, by End User (2017-2030)
15.2.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.11.5. Market Revenue and Forecast, by Type (2017-2030)
15.2.11.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
15.2.11.8. Market Revenue and Forecast, by Lethality (2017-2030)
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.2.12.2. Market Revenue and Forecast, by Product (2017-2030)
15.2.12.3. Market Revenue and Forecast, by End User (2017-2030)
15.2.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.12.5. Market Revenue and Forecast, by Type (2017-2030)
15.2.12.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.2.12.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.2.12.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.3. APAC
15.3.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.3.2. Market Revenue and Forecast, by Product (2017-2030)
15.3.3. Market Revenue and Forecast, by End User (2017-2030)
15.3.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.5. Market Revenue and Forecast, by Type (2017-2030)
15.3.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.3.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.3.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.3.9. India
15.3.9.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.3.9.2. Market Revenue and Forecast, by Product (2017-2030)
15.3.9.3. Market Revenue and Forecast, by End User (2017-2030)
15.3.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.9.5. Market Revenue and Forecast, by Type (2017-2030)
15.3.9.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.3.9.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.3.9.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.3.10. China
15.3.10.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
15.3.10.3. Market Revenue and Forecast, by End User (2017-2030)
15.3.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.10.5. Market Revenue and Forecast, by Type (2017-2030)
15.3.10.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.3.10.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.3.10.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.3.11. Japan
15.3.11.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.3.11.2. Market Revenue and Forecast, by Product (2017-2030)
15.3.11.3. Market Revenue and Forecast, by End User (2017-2030)
15.3.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.11.5. Market Revenue and Forecast, by Type (2017-2030)
15.3.11.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.3.11.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.3.11.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.3.12.2. Market Revenue and Forecast, by Product (2017-2030)
15.3.12.3. Market Revenue and Forecast, by End User (2017-2030)
15.3.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.12.5. Market Revenue and Forecast, by Type (2017-2030)
15.3.12.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.3.12.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.3.12.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.4. MEA
15.4.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.4.2. Market Revenue and Forecast, by Product (2017-2030)
15.4.3. Market Revenue and Forecast, by End User (2017-2030)
15.4.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.5. Market Revenue and Forecast, by Type (2017-2030)
15.4.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.4.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.4.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.4.9. GCC
15.4.9.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.4.9.2. Market Revenue and Forecast, by Product (2017-2030)
15.4.9.3. Market Revenue and Forecast, by End User (2017-2030)
15.4.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.9.5. Market Revenue and Forecast, by Type (2017-2030)
15.4.9.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.4.9.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.4.9.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.4.10. North Africa
15.4.10.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
15.4.10.3. Market Revenue and Forecast, by End User (2017-2030)
15.4.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.10.5. Market Revenue and Forecast, by Type (2017-2030)
15.4.10.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.4.10.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.4.10.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.4.11. South Africa
15.4.11.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.4.11.2. Market Revenue and Forecast, by Product (2017-2030)
15.4.11.3. Market Revenue and Forecast, by End User (2017-2030)
15.4.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.11.5. Market Revenue and Forecast, by Type (2017-2030)
15.4.11.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.4.11.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.4.11.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.4.12.2. Market Revenue and Forecast, by Product (2017-2030)
15.4.12.3. Market Revenue and Forecast, by End User (2017-2030)
15.4.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.12.5. Market Revenue and Forecast, by Type (2017-2030)
15.4.12.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.4.12.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.4.12.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.5. Latin America
15.5.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.5.2. Market Revenue and Forecast, by Product (2017-2030)
15.5.3. Market Revenue and Forecast, by End User (2017-2030)
15.5.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.5. Market Revenue and Forecast, by Type (2017-2030)
15.5.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.5.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.5.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.5.9. Brazil
15.5.9.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.5.9.2. Market Revenue and Forecast, by Product (2017-2030)
15.5.9.3. Market Revenue and Forecast, by End User (2017-2030)
15.5.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.9.5. Market Revenue and Forecast, by Type (2017-2030)
15.5.9.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.5.9.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.5.9.8. Market Revenue and Forecast, by End-Use (2017-2030)
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Forecast, by Caliber (2017-2030)
15.5.10.2. Market Revenue and Forecast, by Product (2017-2030)
15.5.10.3. Market Revenue and Forecast, by End User (2017-2030)
15.5.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.10.5. Market Revenue and Forecast, by Type (2017-2030)
15.5.10.6. Market Revenue and Forecast, by Guidance (2017-2030)
15.5.10.7. Market Revenue and Forecast, by Lethality (2017-2030)
15.5.10.8. Market Revenue and Forecast, by End-Use (2017-2030)
16.1. Northrop Grumman Corporation
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. FN Herstal
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. Olin Corporation
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. General Dynamics Corporation
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. BAE Systems, Inc.
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Rheinmetall Defense
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. Nexter KNDS Group
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. Hanwha Corporation
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. ST Engineering
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. Remington Arms Company LLC
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
18.1. About Us
18.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client